10 Province supplies band purchase price information published (attached list)

On August 6th, Shaanxi Provincial Public Resources Trading Center issued the Notice on Matters Related to the Inter-Regional Joint Zone Purchase Bargaining of Artificial Crystals in Inter-provincial Alliance Public Medical Institutions (hereinafter referred to as the Notice), and the declared prices corresponding to the group of procurement products for public quantity procurement and for arms enterprises.
According to Cypress blue equipment statistics, this volume procurement involves Erkang, Dr. Lun, Ebernod, China Resources Guangdong, Shanghai Pharmaceutical Holdings and other 22 pharmaceutical enterprises, a total of 17 sets of catalogs, 124 specific varieties.
Of these, Erkang involves 13 specific varieties such as single focus, double focus, triple focus, scattering, diffraction, etc., and Dr. Len involves a non-pre-installed single-focus non-spirth hydrophobic, single-focus non-sphear hydrophobic three non-pre-installed and other 7 specific varieties Ebonod involves 5 specific varieties in a pre-loaded single-focus non-spahf hydrophobic hydrophobic piece, and Shanghai Pharmaceutical Holdings involves 13 specific varieties such as single-focus non-spline hydrophobic pro-water non-pre-installed, single-focus non-spline hydrophobic one pre-installed, diffraction, etc.
for price information, according to Cypress blue equipment statistics, the declared price from 229 yuan to 25,000 yuan.
e.g., the declared price of Erkang's three-coke artificial crystal is 25,000 yuan, the declared price of diffraction artificial crystals of Shanghai Pharmaceutical Holdings is 23,888 yuan, and the single-focus spheel hydroponic hydroponic hydroponic piece of non-pre-installed artificial crystal of Zhuhai Xiangle Medical Device Co., Ltd. The declared price of the body is 350 yuan, the declared price of a non-pre-installed artificial crystal body of Wuhan Hehengyuan Investment Co., Ltd. is 229 yuan, and the "Notice" shows that the bargaining time is from 9 a.m. on August 15, 2020.
National public medical institutions in Ningxia, Gansu, Qinghai, Xinjiang, Xinjiang Construction Corps, Hunan, Guangxi, Guizhou, Hainan and Shaanxi provinces (regions, corps) and secondary public medical institutions with artificial crystal-related surgery will participate in this joint volume procurement.
low price is to take note of, this volume procurement is no longer only low price is to take, but to consider the enterprise and products of many factors.
The Notice shows that the number of products declared in each group is more than 6 (including 6) and requires a group of expert group ratings.
group of experts scored in five dimensions: enterprise size (10 points), product quality and safety (40 points), market share (10 points), service training (20 points), and supply security capability (20 points).
Of these, the two dimensions of enterprise size and market share are objective points, which shall be assigned by the centralized purchasing group according to the enterprise declaration information (2019 annual enterprise tax report), and the provinces shall report the artificial crystal procurement data according to the scoring rules.
other three dimensions are assigned by expert group members in combination with clinical use, enterprise on-site product statements and other factors.
the results assigned by the expert to remove one highest score and one lowest score, take the average of the remaining points, for the final score of the product.
product quality and safety (40 points) includes the incidence of adverse product events, the incidence of complications associated with cataract surgery, retardation range and patient satisfaction 4, each accounted for 10 points.
supply support capacity (20 points) is divided into production capacity, distribution capacity and emergency response capacity, respectively, 10 points, 5 points, 5 points.
market share (10 points) is based on provincial reporting statistics and is calculated according to the following formula: the share of the declared varieties / the quantity of all varieties in the same group x 100%.
10 per cent or more, 10 points, 5-10 per cent (including 5 per cent) 8 points, less than 5 per cent (including 1 per cent) 6 points, and no reporting data 2 points.
previously published "Inter-provincial alliance public medical institutions artificial crystal cross-regional joint belt volume procurement document" shows that the number of products to be selected in 3 in 2, 5 in 3, 7 in 4, 9 in 5, 10 in 6.
number of actual declared products eligible for the declared varieties in the same group is more than 6, the finalists are determined by two rounds of expert group scoring and product quotation scoring.
The first round of expert groups from the enterprise scale, product quality and safety and other aspects of product quality and other aspects of product quality, the elimination of a number of armed enterprises, including the number of products 6 to 7 phase-out 1, 8 to 9 phase-out 2, more than 10 elimination of at least 2, the maximum retention of 10.
second round according to the enterprise site final quotation, from low to high order, to determine the proposed selected enterprises.
the above procurement documents show that the provinces (regions) from each group of selected products, in principle, according to not more than 3 products, to determine the province (regions) of the selected products.
at the same time for the purchase volume of 3 products, "procurement documents" show that the price of 300 yuan, 400 yuan, 500 yuan for example, the corresponding procurement volume is 42.55 percent, 31.91 percent, 25.53 percent.
Huahua recruitment network senior consultant, pharmaceutical procurement platform experts, Cypress Blue special lecturer Li Zhixuan has told Saibai blue equipment, the provinces to choose 3 products may have a certain impact on the past market pattern, from the purchase of the percentage of the number, if the same group of bid price difference is not big, then the first three procurement quantity gap will not be too large.
Therefore, the final market share is more even, the original occupy a larger market share of products, after the election market share may be reduced, the original less well-known, small sales of products, after the election market share may be increased.
Limu Information Consulting released a report shows that from the current market competition pattern, Alcon, Eye Health and Dr. Lun three companies monopolize the global market share of artificial crystals more than 80%, the domestic market is more obvious, imported brands occupy more than 95% of the domestic soft crystal market market share.
it is understood that, in addition to this Shaanxi 10 provincial alliance, the 3 plus 6 alliance has also carried out joint belt procurement of artificial crystal supplies.
In May this year, Beijing-Tianjin-Yuan and Heji Liaomon Jinlu Pharmaceutical Joint Purchasing Office announced the results of the selection of artificial crystal supplies, the selected enterprises include Johnson and Johnson Vision, Ebernod, the United States Erkang, Wuxi Leiming Vision Kang and other enterprises (the end of the article attached to the winning list of enterprises and prices).
according to people's network news, a total of 22 eligible enterprises participated in the procurement of the 3-plus-six alliance, of which 13 groups formed full competition, a total of 25 products identified as the proposed selection.
, compared with the original purchase price in the joint procurement area, the proposed price decreased by an average of 54.21 per cent, with a maximum decrease of 84.73 per cent.
attachment: